Risk of cutaneous adverse events in cancer patients treated with phosphatidylinositol-3-kinase inhibitors: A systematic review and meta-analysis of randomized controlled trials.

Cancer Med · 2023 · PMC9939201 · PMID 35986570

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline level of statistical significanceno p-value reported

However, the p value in the between‐subgroup (χ 2 p = 0.06) was on a borderline level of statistical significance, which indicated that PI3K inhibitor types may be associated with a rash.

also in 49 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.